Comparison between two drugs for pain relief after spine surgery

An Randomised Comparative Study to Compare the efficacy of Dexmedetomidine vs Dexamethasone as an adjuvant with Ropivacaine in Erector Spinae Block in Lumbar Spine Surgery under General Anaesthesia - Nil

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/06/088680

Enrollment

Registered

2025-06-12

Start date

Unknown

Completion date

Unknown

Last updated

2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: -

Interventions

Intervention1: Dexmedetomidine as an Adjuvant with Ropivacaine: The efficacy of dexmedetomidine 25mcg as an adjuvant with ropivacaine 0.375% in erector spinae block in lumbar spine surgery under gener

Eligibility

Inclusion criteria

Inclusion criteria: Patients willing to participate in the study, Patients of ASA grade I, II, III of either gender, Patients undergoing elective lumbar surgery , Age of patients 18-75 years

Exclusion criteria

Exclusion criteria: Patients refusal, Patient belonging to ASA IV, V GRADE , Patients with bleeding and coagulation disorders, Infection at the site

Design outcomes

Primary

Measure	Time frame
To assess the efficacy of dexmedetomidine with 0.375%ropivacaine vs dexamethasone with 0.375%ropivacaine in erector spinae block in lumbar spine surgery under general anaesthesia for intraoperative and postoperative pain management.Timepoint: one hourly for next 24hours post operatively	—

Secondary

Measure	Time frame
The study focuses on assessing both intraoperative & postoperative pain control, comparing parameters such as duration of analgesia, total analgesic consumption, haemodynamic stability, & incidence of side effects.Timepoint: hourly for next 24hours postoperatively	—

Countries

India

Contacts

Public ContactDR BINAY TEJA REDDY

Smt.Bhikiben Kanjibhai Shah Medical Institute and Research Centre

jbmehta.28@gmail.com8866718168

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026